The Department of Veterans Affairs has listed the details about a study using the ReWalk Personal 6.0 Exoskeleton Systems on the National Institutes of Health (NIH) website, announces a news release from ReWalk Robotics Ltd.
The national, multi-center study, called “Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life,” is listed in the NIH website’s clinical trials section.
Key components of the study include: enrollment of 160 participants nationwide; eligibility criteria for study participants; study start date of October 2016; and locations of six participating VA Medical Centers with Spinal Cord Injury Services in California, Florida, Massachusetts, Texas, and Virginia.
“This VA clinical trial is groundbreaking in both its purpose and scope, and will undoubtedly provide a wealth of quality research data to the department’s already impressive research,” says ReWalk CEO Larry Jasinski, in the release.
“ReWalk is glad to provide our technology to enable this critical national study,” he adds.
For more information, visit ReWalk Robotics Ltd.
[Source(s): ReWalk Robotics Ltd, PR Newswire]